A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors

Clinical trial NCT01853306 · COMPLETED

Trial details

NCT number: NCT01853306
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Oncology BRCA Mutated High Grade Serous Ovarian Cancer BRCA Mutated Breast Cancer

Start date: 2013-03-18
Primary completion: 2017-05-03
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.